Elisabetta Munzone

Elisabetta Munzone

UNVERIFIED PROFILE

Are you Elisabetta Munzone?   Register this Author

Register author
Elisabetta Munzone

Elisabetta Munzone

Publications by authors named "Elisabetta Munzone"

Are you Elisabetta Munzone?   Register this Author

52Publications

1253Reads

30Profile Views

Reply to Comments on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines."

Br J Cancer 2019 Oct 17;121(9):806. Epub 2019 Sep 17.

Department of Oncology and Hemato-Oncology University of Milan and Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology, IRCCS, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0577-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888857PMC
October 2019

Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

Expert Rev Anticancer Ther 2018 08 4;18(8):805-814. Epub 2018 Jul 4.

c Epidemiology & Clinical Trials Office , General Hospital , Mirano ( VE ), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1489244DOI Listing
August 2018

Optimal management of luminal breast cancer: how much endocrine therapy is long enough?

Ther Adv Med Oncol 2018 18;10:1758835918777437. Epub 2018 Jun 18.

Division of Medical Senology, European Institute of Oncology, Via Ripamonti, 435, Milano 20141, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918777437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024281PMC
June 2018

Metronomics in the neoadjuvant and adjuvant treatment of breast cancer.

Cancer Lett 2017 08 16;400:259-266. Epub 2017 Jan 16.

Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.12.041DOI Listing
August 2017

Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.

Int J Cancer 2016 Jul 12;139(1):212-9. Epub 2016 Mar 12.

Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30062DOI Listing
July 2016

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

Future Oncol 2016 Feb 19;12(3):373-87. Epub 2015 Nov 19.

Department of Clinical & Experimental Medicine, Division of Pharmacology, University of Pisa, 56126 Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.306DOI Listing
February 2016

Clinical overview of metronomic chemotherapy in breast cancer.

Nat Rev Clin Oncol 2015 Nov 4;12(11):631-44. Epub 2015 Aug 4.

Division of Medical Senology and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.131DOI Listing
November 2015

Picking the optimal endocrine adjuvant treatment for pre-menopausal women.

Breast 2015 Nov 4;24 Suppl 2:S11-4. Epub 2015 Aug 4.

Division of Medical Senology, European Institute of Oncology, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.07.004DOI Listing
November 2015

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.

Drugs 2015 Aug;75(12):1311-21

Division of Medical Senology, and International Breast Cancer Study Group, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-015-0433-7DOI Listing
August 2015

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

Melanoma Res 2015 Jun;25(3):239-45

aOncology of Melanoma Unit bEarly Drug Development for Innovative Therapies Division cDermatoncological Division dDepartment of Epidemiology and Biostatistics, European Institute of Oncology, Milan eRoche S.p.A., Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000146DOI Listing
June 2015

Development and psychometric testing of a breast cancer patient-profiling questionnaire.

Breast Cancer (Dove Med Press) 2015 1;7:133-46. Epub 2015 Jun 1.

Department of Health Science, University of Milan, Milan, Italy ; European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S80014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457218PMC
June 2015

Metronomic therapy and breast cancer: a systematic review.

Cancer Treat Rev 2014 Sep 18;40(8):942-50. Epub 2014 Jun 18.

Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.06.002DOI Listing
September 2014

Highlights from the ninth European breast cancer conference, glasgow, 19-21 march 2014.

Ecancermedicalscience 2014 6;8:426. Epub 2014 May 6.

European Institute of Oncology, Milan 20141, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2014.426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019458PMC
May 2014

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

Hematol Oncol Clin North Am 2013 Aug 18;27(4):703-14, vii-viii. Epub 2013 Jun 18.

Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.05.012DOI Listing
August 2013

Extended adjuvant chemotherapy in endocrine non-responsive disease.

Breast 2013 Aug;22 Suppl 2:S161-4

Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.031DOI Listing
August 2013

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer.

Breast Cancer Res Treat 2012 Jul 1;134(1):277-82. Epub 2012 Apr 1.

Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2040-6DOI Listing
July 2012

Targeting the subtypes of breast cancer: rethinking investigational drugs.

Expert Opin Investig Drugs 2012 Feb 10;21(2):191-204. Epub 2012 Jan 10.

Division of Medical Oncology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.651456DOI Listing
February 2012

Prognostic value of circulating tumor cells in primary and metastatic breast cancer.

Expert Rev Anticancer Ther 2012 Feb;12(2):203-14

European Institute of Oncology, Medical Care Unit, Department of Medical Oncology, Ripamonti Street 435, Milan 20141, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/18/20/5701.ful
Web Search
http://www.tandfonline.com/doi/full/10.1586/era.11.208
Publisher Site
http://dx.doi.org/10.1586/era.11.208DOI Listing
February 2012

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Breast Cancer Res 2006 7;8(1):R4. Epub 2005 Dec 7.

Department of Medicine, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413988PMC
March 2006